Older patients with higher triglyceride levels, mostly within the normal to high range, had lower risk of dementia and slower cognitive decline over time than those with lower triglyceride levels.
A US study has revealed major gaps in the detection of mild cognitive impairment in primary care, with the vast majority of older adults with the condition undiagnosed.
Allopregnanolone has the potential to delay neurodegeneration in early Alzheimer s disease by promoting endogenous systems of renewal and repair, early testing shows.
New data from TRAILBLAZER-ALZ 2 show robust amyloid clearance with donanemab in APOE4 carriers and noncarriers, mitigating the risk of disease progression and dependency.
Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.